Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Kellie JF"'
Autor:
Schneck NA; Analytical Development, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States., Mehl JT; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States., Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, Pennsylvania 19426, United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2023 Sep 06; Vol. 34 (9), pp. 1837-1846. Date of Electronic Publication: 2023 Jul 21.
Autor:
Carle K; Bioanalysis, Immunogenicity & Biomarkers, IVIVT, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA. Electronic address: katie.m.carle@gsk.com., Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, IVIVT, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA., Gunn GR; Bioanalysis, Immunogenicity & Biomarkers, IVIVT, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA., Jiang Y; Bioanalysis, Immunogenicity & Biomarkers, IVIVT, GSK, 1250 S. Collegeville Rd, Collegeville, PA, 19426, USA. Electronic address: yong.2.jiang@gsk.com.
Publikováno v:
Analytical biochemistry [Anal Biochem] 2023 Mar 01; Vol. 664, pp. 115033. Date of Electronic Publication: 2022 Dec 27.
Autor:
Kellie JF; GSK, Collegeville, Pennsylvania 19426, United States., Schneck NA; GSK, Collegeville, Pennsylvania 19426, United States., Causon JC; SCIEX, Concord, ON L4K 4 V8, Canada., Baba T; SCIEX, Concord, ON L4K 4 V8, Canada., Mehl JT; GSK, Collegeville, Pennsylvania 19426, United States., Pohl KI; SCIEX, Framingham, Massachusetts 01701, United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2023 Jan 04; Vol. 34 (1), pp. 17-26. Date of Electronic Publication: 2022 Dec 02.
Autor:
An B; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA. Electronic address: bo.x.an@gsk.com., Sikorski TW; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Schneck NA; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Mehl J; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Tang H; Bioanalysis, Immunogenicity & Biomarkers, In-vitro/In-vivo Translation, R&D Research, GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Qu J; Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences, University at Buffalo, State University of New York, Buffalo, NY 14214, USA; New York State Center of Excellence in Bioinformatics & Life Sciences, Buffalo, NY 14203, USA., Shi T; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Gao Y; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Jacobs JM; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA., Nandita E; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA., van Soest R; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA., Jones E; SCIEX, 1201 Radio Road, Redwood City, CA 94065, USA.
Publikováno v:
Journal of chromatography. A [J Chromatogr A] 2022 Aug 02; Vol. 1676, pp. 463261. Date of Electronic Publication: 2022 Jun 17.
Autor:
Kellie JF; Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Australia (J.F.K., B.C.V.C., N.Y.)., Campbell BCV; Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Australia (J.F.K., B.C.V.C., N.Y.)., Watson R; Department of Medicine, The Royal Melbourne Hospital, University of Melbourne, Australia (R.W., S.C.).; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Australia (R.W., N.Y.)., Praeger AJ; Department of Neurosurgery (A.J.P., G.N.), The Royal Melbourne Hospital, Australia., Nair G; Department of Neurosurgery (A.J.P., G.N.), The Royal Melbourne Hospital, Australia., Murugasu A; Department of Pathology (A.M.), The Royal Melbourne Hospital, Australia., Rowe CC; Department of Molecular Imaging and Therapy, Austin Health, Australia (C.C.R.)., Masters CL; The Florey Institute of Neuroscience and Mental Health, Australia (C.L.M., S.C.)., Collins S; Department of Medicine, The Royal Melbourne Hospital, University of Melbourne, Australia (R.W., S.C.).; The Florey Institute of Neuroscience and Mental Health, Australia (C.L.M., S.C.)., McLean C; Department of Anatomical Pathology, The Alfred Hospital, Australia (C.M.)., Yassi N; Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Australia (J.F.K., B.C.V.C., N.Y.).; Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Australia (R.W., N.Y.).
Publikováno v:
Stroke [Stroke] 2022 Aug; Vol. 53 (8), pp. e369-e374. Date of Electronic Publication: 2022 Jun 30.
Autor:
Kaur S; Genentech, South San Francisco, CA, USA., Alley SC; Seattle Genetics, Bothell, WA, USA., Szapacs M; Abbvie, Philadelphia, PA, USA., Wilson A; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ciccimaro E; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Su D; Mersana, Cambridge, MA, USA., Henderson N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Chen L; Boehringer Ingelheim, Ridgefield, CT, USA., Garofolo F; BRI - a Frontage Company, Vancouver, BC, Canada., Hengel S; Seattle Genetics, Bothell, WA, USA., Jian W; Janssen Research & Development, Spring House, PA, USA., Kellie JF; GlaxoSmithKline, Collegeville, PA, USA., Lee A; Merck, Kenilworth, NJ, USA., Mehl J; GlaxoSmithKline, Collegeville, PA, USA., Palandra J; Pfizer, Andover, MA, USA., Qiu H; Regeneron, Tarrytown, NY, USA., Savoie N; WRIB, Montreal, QC, Canada., Shakleya D; US FDA, Silver Spring, MD, USA., Staelens L; UCB, Braine l'Alleud, Belgium., Sugimoto H; Takeda, Cambridge, MA, USA., Sumner G; Regeneron, Tarrytown, NY, USA., Welink J; EU EMA, Amsterdam, Netherlands., Wheller R; LGC, Fordham, UK., Xue YJ; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Zeng J; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Zhang J; US FDA, Silver Spring, MD, USA., Zhou H; BioMarin, Novato, CA, USA., Wang J; Crinetics, San Diego, CA, USA., Summerfield S; GlaxoSmithKline, Stevenage, UK., Kavetska O; Pfizer, Groton, CT, USA., Dillen L; Janssen Research & Development, Beerse, Belgium., Ramanathan R; Vertex, Boston, MA., Baratta M; Takeda, Cambridge, MA, USA., Dasgupta A; US FDA, Silver Spring, MD, USA., Edmison A; Health Canada, Ottawa, ON, Canada., Ferrari L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Fischer S; Genentech, South San Francisco, CA, USA., Fraier D; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Haidar S; US FDA, Silver Spring, MD, USA., Heermeier K; Sanofi, Frankfurt, Germany., James C; Amgen Research, Thousand Oaks, CA, USA., Ji A; Sanofi, Framingham, MA, USA., Luo L; Pfizer, Groton, CT, USA., Lima Santos GM; Brazil ANVISA, Brasilia, Brazil., Post N; Ionis, Carlsbad, CA, USA., Rosenbaum AI; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA., Sporring S; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, South San Francisco, CA, USA., Surapaneni S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Vinter S; Novo Nordisk, Maaloev, Denmark., Wan K; Pfizer, Groton, CT, USA., Woolf E; UK MHRA, London, UK., Kavetska O; Pfizer, Groton, CT, USA., Cho SJ; US FDA, Silver Spring, MD, USA., Kossary E; WHO, Geneva, Switzerland., Prior S; UK MHRA, London, UK., Abhari MR; US FDA, Silver Spring, MD, USA., Soo C; Health Canada, Ottawa, ON, Canada., Wang YM; US FDA, Silver Spring, MD, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Cherry E; Health Canada, Ottawa, ON, Canada., Cludts I; UK MHRA, London, UK., Ghosh S; US FDA, Silver Spring, MD, USA., Hopper S; UK MHRA, London, UK., Ishii-Watabe A; WHO, Geneva, Switzerland., Kirshner S; US FDA, Silver Spring, MD, USA., Maher K; US FDA, Silver Spring, MD, USA., Maxfield K; US FDA, Silver Spring, MD, USA., Pedras-Vasconcelos J; US FDA, Silver Spring, MD, USA., Saito Y; Japan MHLW, Tokyo, Japan., Smith D; Health Canada, Ottawa, ON, Canada., Solstad T; Norway NoMA, Oslo, Norway., Verthelyi D; US FDA, Silver Spring, MD, USA., Wadhwa M; UK MHRA, London, UK., Wagner L; US FDA, Silver Spring, MD, USA., Waxenecker G; Austria AGES, Vienna, Austria., Yan H; US FDA, Silver Spring, MD, USA., Zhang L; Health Canada, Ottawa, ON, Canada.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 May; Vol. 14 (9), pp. 505-580. Date of Electronic Publication: 2022 May 17.
Autor:
Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States., Tran JC; Biochemical & Cellular Pharmacology, Genentech Inc., South San Francisco, California 94080, United States., Jian W; DMPK, Janssen Research & Development, Johnson & Johnson, Spring House, Pennsylvania 19477, United States., Jones B; Q Squared Solutions, 19 Brown Road, Ithaca, New York 14850, United States., Mehl JT; Bioanalytical Research, Bristol-Myers Squibb, Princeton, New Jersey 08648, United States., Ge Y; Department of Cell and Regenerative Biology, Department of Chemistry, Human Proteomics Program, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States., Henion J; Advion, Inc., 61 Brown Road, Ithaca, New York 14850, United States., Bateman KP; PPDM, Merck & Co., Inc., West Point, Pennsylvania 19486, United States.
Publikováno v:
Journal of the American Society for Mass Spectrometry [J Am Soc Mass Spectrom] 2021 Aug 04; Vol. 32 (8), pp. 1886-1900. Date of Electronic Publication: 2020 Sep 15.
Autor:
Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA., Alelyunas YW; Scientific Operations, Waters Corporation, 34 Maple St, Milford, MA 01757, USA., Albert J; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA., Schneck NA; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA., Chen Z; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA., Sychterz CJ; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA., Edwards I; Scientific Operations, Waters Corporation, 34 Maple St, Milford, MA 01757, USA., Shion H; Scientific Operations, Waters Corporation, 34 Maple St, Milford, MA 01757, USA., Wrona MD; Scientific Operations, Waters Corporation, 34 Maple St, Milford, MA 01757, USA., Szapacs ME; Bioanalysis, Immunogenicity & Biomarkers, GSK, 1250 S. Collegeville Rd., Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2020 Oct; Vol. 12 (19), pp. 1389-1403. Date of Electronic Publication: 2020 Sep 25.
Autor:
Chen Z; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Kellie JF; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Hottenstein CS; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA., Szapacs ME; Bioanalysis, Immunogenicity & Biomarkers, In-Vitro/In-Vivo Translation, R&D Research, GlaxoSmithKline Pharmaceuticals, 1250 South Collegeville Rd, Collegeville, PA 19426, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2020 Oct; Vol. 12 (19), pp. 1353-1362. Date of Electronic Publication: 2020 Aug 24.
Publikováno v:
Analytical chemistry [Anal Chem] 2020 Jun 16; Vol. 92 (12), pp. 8268-8277. Date of Electronic Publication: 2020 May 22.